The randomised double-blind placebo trial was to study the efficacy of the controversial but commonly used drug in post-exposure prophylaxis — or as a preventive measure in high-risk contacts such as those who were living with a Covid-19 positive patient.from Industry-Economic Times
Read The Rest:economictimes...
